Who are Nest Genomics's investors?

Nest Genomics's investors include 8VC, BlueCross BlueShield Venture Partners, Amboy Street Ventures, SpringTide Ventures, MVP Ventures, Health 2047 Capital Partners.

When was Nest Genomics founded?

Nest Genomics was founded in 2022.

Where is Nest Genomics headquartered?

Nest Genomics is headquartered in New York, New York, United States.

What industry is Nest Genomics in?

Nest Genomics operates in Digital Health, Genomics, Healthcare, SaaS.

How many employees does Nest Genomics have?

Nest Genomics has 11-50 employees.

Nest Genomics

Software to launch and integrate genetics into clinical care

New York, United States · Founded 2022

YC W22

Headquarters: New York, New York
Employees: 11–50
Founded: 2022

Website: nestgenomics.com
Last Round: Series ANov 2025
Rounds: 3

About

Nest is a lab-agnostic, comprehensive solution for organizations to launch and implement large-scale genomic programs. The platform includes the ability to triage, consent, and counsel patients for genetic testing, provide EMR-integrated clinical decision support for providers managing patients with genetic results, and manage patients’ clinical needs across the continuum of care.

Summary

Nest Genomics is a Digital Health company based in New York, United States, founded in 2022. Its most recent funding was a Series A round in Nov 2025. Investors include 8VC, BlueCross BlueShield Venture Partners and Amboy Street Ventures.